An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer

The rise of nanotechnology has opened new horizons for cancer immunotherapy. However, most nanovaccines fabricated with nanomaterials suffer from carrier-related concerns, including low drug loading capacity, unpredictable metabolism, and potential systemic toxicity, which bring obstacles for their...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yunting, Jiang, Min, Du, Guangsheng, Zhong, Xiaofang, He, Chunting, Qin, Ming, Hou, Yingying, Liu, Rong, Sun, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465870/
https://www.ncbi.nlm.nih.gov/pubmed/37655327
http://dx.doi.org/10.1016/j.apsb.2022.03.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10465870/
https://www.ncbi.nlm.nih.gov/pubmed/37655327
http://dx.doi.org/10.1016/j.apsb.2022.03.017

Ejemplares similares